What are the drugs for the early stage of breast cancer?
The drugs for early breast cancer include the following categories: 1. Hormonal receptor regulator, such as tamoxifen, toremifen, can be used in breast cancer patients with hormone receptor-positive before and after menstruation. 2. Aromatase inhibition drugs, such as letrozuo, anastrozuo, and eximestane, were mainly used in post-menstrual patients. They could also be used in combination with belly acupuncture before menstruation. 3. Ovary function suppressors (commonly known as belly needles): Representative drugs include goserelin and leuprorelin, which are suitable for breast cancer patients with premenstrual hormone receptor-positive. Read more exciting novels for free
What are the drugs for early chemotherapy of breast cancer?
The liver-protecting drugs used for early chemotherapy of breast cancer included liver-protecting tablets, Glutathion tablets, Compound Ammine Glycerate injection, Diammine Glycerate Enteric capsules, Dicyclol tablets, and Yishanfu Polyene Phospholipidoline capsules. These drugs needed to be used under the guidance of a doctor. For example, liver-protecting tablets could protect the liver; Glutathione-based tablets could repair stem cells and detoxify; and compound licorice injection could protect the liver and improve the pain symptoms caused by liver damage. The bicyclol tablets had a good effect on reducing the index of Gu and C, but the effect on the index of Gu and Cao was not ideal. The Yishanfu Duoene Phospholidylcholin capsules did not improve the high index of transferment in some patients. Regarding the kidney protection drugs for early chemotherapy of breast cancer, the reference materials did not explicitly mention the relevant drugs. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the side effects of breast cancer chemotherapy drugs?
The side effects of breast cancer chemotherapy drugs were as follows: 1. Bone marrow suppression: - White blood cell reduction was more common. For example, white blood cell reduction was more common after the use of cyclosporine, and the lowest value was 1 - 2 weeks after the use of cyclosporine. Most of them recovered after 2 - 3 weeks. The strength of bone marrow suppression caused by anthracyclines was higher than that of cyclosporine. Bone marrow suppression was more likely to occur when taxane drugs were used in combination with cyclosporine. Bone marrow suppression could lead to low white blood cells, low blood counts, and even leukemia. Neutropiuria could also be accompanied by infection. 2. ** Intestinal reaction **: - This included loss of appetite, nausea, vomiting, diarrhea, or constipation. Cyclocyclosporine's digestive tract reactions were manifested as loss of appetite, nausea and vomiting, which generally disappeared after stopping the drug for 1 - 3 days. Anthracyclines would cause digestive disorder, such as nausea, vomiting and diarrhea. The digestive tract reactions of taxane drugs were common but not serious, and a few could have diarrhea. 3. ** Cardiac toxicity (mainly due to anthracyclines)**: - The greater the dosage, the greater the cardiac toxicity. There were three types according to the time of appearance: - Acuteness: It often occurs within a few hours or days after administration, and is manifested as cardiac transmission disorder and cardiac arrest. In a few cases, it is manifested as pericarditis and acute left heart failure. - "Chronical: It occurs within 1 year of chemotherapy, and it is manifested as left cardiovascular malfunction, which can eventually lead to heart failure." - Late-onset: It occurs several years after chemotherapy, and may manifest as heart failure, myocardiopathic disease, and cardiac arrest. 4. ** Hair Loss **: - 60 - 90% of patients who took the anthracyclines would have hair loss, which was generally irreversible. After stopping the drug, hair would grow back; mild hair loss was more common with taxane drugs; taxol, a commonly used drug for breast cancer, could also cause hair loss. 5. ** Others **: - Cytoxan has urological reactions. If a large dose of cyclosporine is used and there is no effective preventive measures, it can cause bleeding cystitis, which is manifested as bladder irritation symptoms, oliguria, hematuria, and proteinuria. The occurrence rate is relatively low when the conventional dose is used. There may also be stomatitis, toxic leukemia, skin hyperchrominosis, menstrual disorder, and lung edema. Poisonous Poisonous (appearing on the side of the tongue and sub-tongue on the fifth to tenth day of medication). There were reports of occasional fever, chills, hives, hyperchromism, and joint pain; Allergy to yew drugs (Paclitaxel-like and taxotere can cause it, but not taxol. Pretreatment with hormones and other drugs is required before infusion. The drip rate can be adjusted for mild symptoms. For serious reactions, the drug should be stopped.), peripheral nervous system toxicity (Numbness of fingers and toes is the most common. Obvious sensory and motor disturbances and decreased tendon reflexes may occur at high doses. Grand mal seizure during infusion is reported in some cases.), cardiovascular toxicity (Temporary heart rate and low blood pressure are more common), joint and muscle pain (about half of the patients will feel pain 2 - 3 days after taking the medicine, which is related to the dosage and will recover within a few days. When combined with the White Increasing Needle, the muscle pain will worsen), changes in the liver and gallbladder system (such as elevation of Bilirubin, Alkaline Phosphatase, and Glutamate Oxalic Transaminases in some patients after taking taxol). In addition, chemotherapy drugs could also cause local reactions, such as phlebitis caused by chemotherapy drugs, local skin rupture and necrosis caused by drug exudate, as well as immune suppression, which would cause the body's immune function to be low and the resistance to infection. There were also internal organ damage, such as liver and kidney function damage. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Stage 4 Breast Cancer Success Stories: What Are They?
There are some cases where patients with stage 4 breast cancer have had success. Some patients respond well to new targeted therapies. For example, a woman named Jane. She was diagnosed with stage 4 breast cancer. But through a combination of immunotherapy and hormonal therapy, her tumors shrank significantly. Her doctors were able to keep her cancer in check for a long time, and she is now living a relatively normal life, traveling and spending time with her family.
What are the drugs in the stage 3 chemotherapy plan for sigmoid cancer?
The more commonly accepted chemotherapy plan for stage 3 sigmoid cancer was the Xelox plan, which mainly consisted of two kinds of chemotherapy drugs. One was oxaliplatinum, which required intravenous infusion, and the other was oral capecitobin (Xeloda). The two drugs were used together. However, the specific chemotherapy plan and medication needed to be consulted with the doctor. The doctor would determine it based on the patient's physique and pathological examination results. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the side effects of oral hormonal drugs for breast cancer?
The following side effects may occur in breast cancer patients who take oral hormonal drugs: 1. Menopacus-like symptoms, such as hot flashes, night sweats, dry vaginas, itching, etc., may also appear anxiety, insomnia and other psychological symptoms, which is a direct manifestation of the decrease in the level of estrogens in the body caused by drugs. 2. Hot flashes, joint pain, bone loss, cardiovascular disease, etc. may occur. 3. For patients who took tamoxifen, there was a possibility of the development of Endometrial Cancer, so they needed to undergo regular gynecology examinations. 4. Taking an Aromatase Inhibition may cause bone thinning. 5. Luteinizing Hormone-Releasing Hormone-Anomalies may cause adverse reactions such as hot flashes, decreased libido, and mood changes. They may also have adverse reactions to bone thinning and the cardiovascular system. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Do breast cancer chemotherapy drugs affect liver function?
The drugs used to treat breast cancer had an effect on liver function. For example, among the commonly used chemotherapy drugs for breast cancer, cyclosporine may cause adverse reactions such as toxic hepatectomy, while anthracyclines may have side effects such as cardiac toxicity, bone marrow suppression, hair loss, myospasm, and gastric and intestinal disturbances. Although the effect on liver function was not explicitly mentioned, the overall toxicity of the drug may indirectly affect liver function. The main toxic reactions of taxane drugs were concentrated in blood toxicity, allergic reactions, peripheral nervous system toxicity, etc. However, multi-drug combination chemotherapy may also affect liver function. In addition, some breast cancer patients showed obvious liver damage after chemotherapy. Their transminase levels rose to more than 1000 (normally, it was only 40). This situation needed to be taken seriously and liver protection and supportive treatment should be carried out in time. It is recommended that the liver function should be checked regularly during the chemotherapy period. If there is damage, the liver protection should be given. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Vomiting in the early stage of gastric cancer
The characteristics of vomiting in the early stage of gastric cancer mainly included the following aspects: 1. Vomiting gradually worsened: Some patients may have symptoms of vomiting. At first, they only had occasional nausea and vomiting, but as the disease progressed, the symptoms of vomiting gradually worsened, and the frequency increased. In the later stages, violent vomiting may occur. 2. Vomiting odor gradually increases: Some stomach cancer can gradually cause obstruction of the esophagus, causing food to stagnate in the stomach for a long time, which will cause food to be sour and smelly, so the sour smell during vomiting will gradually increase. 3. Blood in vomit: There is no blood in the vomit in the early stage. As the condition worsened, the vomiting became more and more serious, and there would be symptoms of vomiting blood. Clinically, 80% of early-stage stomach cancer was basically silent. Therefore, it was not possible to determine whether stomach cancer existed based on whether there were symptoms such as vomiting. Instead, it was necessary to go to the digestive department of the hospital for a gastroscopy examination to confirm the diagnosis. Once stomach cancer was diagnosed, it should be actively treated.
What are the common factors in stage 3 breast cancer success stories?
In many stage 3 breast cancer success cases, patients were vigilant about their follow - up care. After the initial treatment, they continued to have regular check - ups, scans, and tests. This allowed for early detection of any potential recurrence. Some also made lifestyle changes like quitting smoking, reducing alcohol intake, and increasing physical activity. These changes can improve overall health and potentially reduce the risk of the cancer coming back.
Can Back Pain Be an Early Sign of Breast Cancer?
Back pain can be an early sign, but it's very rare. Usually, breast cancer is detected through breast lumps, changes in the breast skin, or nipple discharge first. However, if there is a genetic predisposition or some other factors, breast cancer cells might metastasize to the spine early and cause back pain.
Can early-stage liver cancer be 100% cured?
Early-stage liver cancer could not be completely cured. Early-stage liver cancer usually referred to stage I liver cancer, when the tumor had not spread. The cure rate of early-stage liver cancer depended on many factors, including the size, location, spread of the tumor, and the overall health of the patient. For early-stage liver cancer that was confined to the liver, if the surgical conditions were met, a higher cure rate could usually be achieved by surgical removal of the tumor. According to research, the cure rate of early-stage liver cancer surgery could exceed 60% or even higher. However, even if the surgery was successful, there was still a risk of relapse. Therefore, follow-up and monitoring after surgery were crucial, as well as taking necessary preventive measures, such as improving lifestyle, regular checkups, and following the doctor's recommendations. In summary, early-stage liver cancer could not be cured 100%, but through early detection, early diagnosis, and early treatment, the prognosis and quality of life of patients could be significantly improved, and the lifespan of patients could be extended.